By using sequential in vivo recombination, they showed that FOXA1/2 loss in established KRAS-driven neoplasia originating from SPC+ alveolar cells was capable of promoting keratinizing squamous cell carcinomas, illustrating the capacity of these transcription factors to cause transdifferentiation. This evidence concerns the gene FOXA1 and neoplasm.